A Prospective Multicenter Study Using a Virtual 3 Fr Percutaneous Coronary Intervention System: The V3 Registry.

Fuminobu Yoshimachi(Tokai University Hachioji Hospital), Yuji Ikari(Tokai University), Tsuyoshi Honda, Shigeru Saito(Shonan Kamakura General Hospital), Satoru Tohara(Saitama Prefectural Kasukabe Special Support School), Hidenobu Terai(Kanazawa Hospital), Yoshitoki Takagawa, Tomoyasu Shin, Masanori Takada, Hiroaki Koiwa, Akihiko Takahashi(Kitasato University), Noriyuki Kinoshita, Nobuo Shiode(Hiroshima General Hospital), Yoshihisa Shimada(Osaka City University), Hiroshi Asano(Tosei General Hospital), Kunihiro Yamada, Motomaru Masutani(Bio-Rad (United States)), Takaaki Katsuki(Jichi Medical University), Hiroshi Ueno(University of Toyama), Satoshi Takeshita(The Nakamura Hajime Eastern Institute), Takashi Matsukage(Tokai University)
PubMed
January 1, 2017
Cited by 15

Related Papers

Effect of 1-Month Dual Antiplatelet Therapy Followed by Clopidogrel vs 12-Month Dual Antiplatelet Therapy on Cardiovascular and Bleeding Events in Patients Receiving PCI
|JAMA|2019|848
Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation
|Circulation|2009|358
T wave peak-to-end interval and QT dispersion in acquired long QT syndrome: a new index for arrhythmogenicity
|Clinical Science|2003|313
Comparison of Clopidogrel Monotherapy After 1 to 2 Months of Dual Antiplatelet Therapy With 12 Months of Dual Antiplatelet Therapy in Patients With Acute Coronary Syndrome
|JAMA Cardiology|2022|313
Therapeutic Angiogenesis Induced by Human Recombinant Hepatocyte Growth Factor in Rabbit Hind Limb Ischemia Model as Cytokine Supplement Therapy
|Hypertension|1999|271